Treatment duration
If you use other medications containing calcipotriol, the total amount of medications containing calcipotriol should not exceed 15 grams per day and the treated area should not exceed 30% of the total body surface area.
What should I expect when using Psotriol?
Most patients observe obvious results in 2 weeks, even if the psoriasis has not yet faded at that time.
If you use more Psotriol than you should
Consult your doctor if you have used more than 15 grams per day. Excessive use of Psotriol may cause a problem with your blood calcium, which usually normalizes when the treatment is interrupted. Your doctor may need to perform a blood test to evaluate whether excessive use of the gel has caused a problem with your blood calcium. Prolonged and excessive use may also cause your adrenal glands to malfunction (located near the kidneys and produce hormones).
Contact the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount used.
If you forget to use Psotriol
Do not apply a double dose to compensate for the missed doses.
If you interrupt the treatment with Psotriol
The use of Psotriol should be ended as indicated by your doctor. It may be necessary to end the use of this medication gradually, especially if you have been using it for a long time.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Severe side effects
Inform your doctor or nurse immediately or as soon as possible if you experience any of the following severe side effects. You may need to stop treatment.
Rare (may affect up to 1 in 100 people)
We know that some severe side effects are caused by betamethasone (a potent steroid), one of the components of Psotriol. If you experience any of the severe side effects, inform your doctor as soon as possible. These side effects are more likely to occur after long-term use, when used in skin folds (e.g. elbows, armpits or under the breasts), when the area is covered or when used on large areas of skin.
The side effects include the following:
Severe side effects caused by calcipotriol
Mild side effects
Frequent side effects (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Frequency not known (the frequency cannot be estimated from available data):
• The hair may turn temporarily yellowish in color at the application site when used on the scalp.
• Blurred vision.
Mild side effects caused by the use of betamethasone, especially over a prolonged period, include the following. If you notice any of them, inform your doctor or nurse as soon as possible.
Mild side effects caused by calcipotriol include the following:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and the bottle after EXP. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30 °C.
The bottle must be discarded with the remaining gel 6 months after the first opening.
Medications should not be thrown down the drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. In this way, you will help protect the environment.
Composition of Psotriol 50 micrograms/g + 0.5 mg/g gel
The active principles are:
Calcipotriol and betamethasone.
One gram of gel contains 50 micrograms of calcipotriol (as monohydrate) and 0.5 mg of betamethasone (as dipropionate).
The other components are:
Liquid paraffin, polioxypropylene ester, hydrogenated ricin oil, butylhydroxytoluene (E321).
Appearance of the product and contents of the package
Psotriol 50 micrograms/g + 0.5 mg/g gel is a nearly transparent, colorless to slightly white gel that is presented in screw-top polyethylene bottles.
Bottle sizes: 15 g, 30 g, 35 g, 50 g, 60 g, 100 g, and 120 g.
Only some package sizes may be commercially available.
Holder of the marketing authorization and manufacturer responsible
Holder of the marketing authorization
Mibe Pharma España S.L.U.
C/Amaltea 9, 4th floor, letter B,
28045, Madrid
Spain
Manufacturer responsible
Mibe GmbH Arzneimittel
Münchener Strasse 15
06796 - Brehna
Germany
Or
Sun-Farm Sp. z o.o.
Ul. Dolna 21
Mazowieckie
05-092 Lomianki
Poland
This medicine is authorized in the member states of the European Economic Area with the following names:
Austria:Calcidermetha 50 Mikrogramm/g + 0.5 mg/g Gel
Belgium:Calcipotriol/Betamethasone Dermapharm 50 micrograms/g + 0.5 mg/g gel
Calcipotriol/Betamethasone Dermapharm 50 microgrammes/g + 0.5 mg/g gel
Calcipotriol/Betamethasone Dermapharm 50 Mikrogramm/g + 0.5 mg/g Gel
Germany:Calcipotriderm comp. 50 Mikrogramm/g + 0.5 mg/g Gel
Spain:Psotriol 50 micrograms/g + 0.5 mg/g gel
Croatia:Psotriol 50 mikrograma/g + 0.5 mg/g gel
Italy:Psotriol
Poland:Psotriol
Last review date of this leaflet: March 2020
For detailed and updated information on this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.